BBNX logo

Beta Bionics, Inc. (BBNX) Cash From Financing

Annual CFF:

$55.62M-$45.41M(-44.95%)
December 31, 2024

Summary

  • As of today, BBNX annual cash from financing is $55.62 million, with the most recent change of -$45.41 million (-44.95%) on December 31, 2024.
  • During the last 3 years, BBNX annual cash from financing has fallen by -$1.17 million (-2.06%).
  • BBNX annual cash from financing is now -44.95% below its all-time high of $101.03 million, reached on December 31, 2023.

Performance

1-Year Change

-44.95%

3-Year Change

-2.06%

5-Year Change

-2.06%

15-Year Change

-2.06%

BBNX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

75.92%
BBNX annual cash from financing is higher than 75.92% of companies in Healthcare sector

Range

All-Time High

$101.03M
BBNX annual cash from financing is currently -44.95% below its historical high of $101.03 million

3-Year Low

$55.62M
BBNX annual cash from financing is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BBNX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
BBNX next annual earnings announcement has not yet been scheduled

OtherBBNXcash flow metrics

Annual CFI

-$3.48M
BBNX annual cash from investing is -$3.48 million

Annual CFO

-$48.27M
BBNX annual cash from operations is -$48.27 million

Annual FCF

-$51.67M
BBNX annual free cash flow is -$51.67 million

Annual CAPEX

$3.40M
BBNX annual capital expenditures is $3.40 million

Quarterly CFF:

$42.00K-$211.08M(-99.98%)
June 30, 2025

Summary

  • As of today, BBNX quarterly cash from financing is $42.00 thousand, with the most recent change of -$211.08 million (-99.98%) on June 30, 2025.
  • Over the past year, BBNX quarterly cash from financing has increased by +$149.00 thousand (+139.25%).
  • BBNX quarterly cash from financing is now -99.98% below its all-time high of $211.12 million, reached on March 31, 2025.

Performance

3-Month Change

-99.98%

1-Year Change

+139.25%

3-Year Change

-99.96%

5-Year Change

-99.96%

BBNX Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

48.56%
BBNX quarterly cash from financing is higher than 48.56% of companies in Healthcare sector

Range

All-Time High

$211.12M
BBNX quarterly cash from financing is currently -99.98% below its historical high of $211.12 million

3-Year Low

-$1.18M
BBNX quarterly cash from financing is currently +103.57% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
BBNX previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 28, 2025
BBNX next earnings announcement is scheduled for Oct 28, 2025

OtherBBNXcash flow metrics

Quarterly CFI

$6.17M
BBNX quarterly cash from investing is $6.17 million

Quarterly CFO

-$13.59M
BBNX quarterly cash from operations is -$13.59 million

Quarterly FCF

-$15.37M
BBNX quarterly free cash flow is -$15.37 million

Quarterly CAPEX

$1.78M
BBNX quarterly capital expenditures is $1.78 million

TTM CFF:

$266.88M+$149.00K(+0.06%)
June 30, 2025

Summary

  • As of today, BBNX TTM cash from financing is $266.88 million, with the most recent change of +$149.00 thousand (+0.06%) on June 30, 2025.
  • Over the past year, BBNX TTM cash from financing has increased by +$165.95 million (+164.42%).
  • BBNX TTM cash from financing is now at all-time high.

Performance

3-Month Change

+0.06%

1-Year Change

+164.42%

3-Year Change

+164.18%

5-Year Change

+164.18%

BBNX TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

95.96%
BBNX TTM cash from financing is higher than 95.96% of companies in Healthcare sector

Range

All-Time High

$266.88M
BBNX TTM cash from financing is currently at an all-time high

3-Year Low

-$1.27M
BBNX TTM cash from financing is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
BBNX previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 28, 2025
BBNX next earnings announcement is scheduled for Oct 28, 2025

OtherBBNXcash flow metrics

TTM CFI

-$187.37M
BBNX TTM cash from investing is -$187.37 million

TTM CFO

-$57.46M
BBNX TTM cash from operations is -$57.46 million

TTM FCF

-$62.05M
BBNX TTM free cash flow is -$62.05 million

TTM CAPEX

$4.59M
BBNX TTM capital expenditures is $4.59 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BBNX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-45.0%+139.3%+164.4%
3Y3 Years-2.1%-100.0%+164.2%
5Y5 Years-2.1%-100.0%+164.2%

BBNX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-45.0%at low-100.0%+103.6%at high>+9999.0%
5Y5-Year-45.0%at low-100.0%+103.6%at high>+9999.0%
All-TimeAll-Time-45.0%at low-100.0%+103.6%at high>+9999.0%

BBNX Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
$42.00K(-100.0%)
$266.88M(+0.1%)
Mar 2025
-
$211.12M(+271.1%)
$266.73M(+379.6%)
Dec 2024
$55.62M
$56.89M(+4937.8%)
$55.62M(+4486.0%)
Sep 2024
-
-$1.18M(-999.1%)
-$1.27M(-101.3%)
DateAnnualQuarterlyTTM
Jun 2024
-
-$107.00K(-1883.3%)
$100.93M(-0.1%)
Mar 2024
-
$6000.00(-33.3%)
$101.03M(+0.0%)
Dec 2023
$101.03M(+77.9%)
$9000.00(-100.0%)
$101.03M(+0.0%)
Sep 2023
-
$101.02M
$101.02M
Dec 2022
$56.78M
-
-

FAQ

  • What is Beta Bionics, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. annual cash from financing year-on-year change?
  • What is Beta Bionics, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. quarterly cash from financing year-on-year change?
  • What is Beta Bionics, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. TTM cash from financing year-on-year change?

What is Beta Bionics, Inc. annual cash from financing?

The current annual cash from financing of BBNX is $55.62M

What is the all-time high annual cash from financing for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high annual cash from financing is $101.03M

What is Beta Bionics, Inc. annual cash from financing year-on-year change?

Over the past year, BBNX annual cash from financing has changed by -$45.41M (-44.95%)

What is Beta Bionics, Inc. quarterly cash from financing?

The current quarterly cash from financing of BBNX is $42.00K

What is the all-time high quarterly cash from financing for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high quarterly cash from financing is $211.12M

What is Beta Bionics, Inc. quarterly cash from financing year-on-year change?

Over the past year, BBNX quarterly cash from financing has changed by +$149.00K (+139.25%)

What is Beta Bionics, Inc. TTM cash from financing?

The current TTM cash from financing of BBNX is $266.88M

What is the all-time high TTM cash from financing for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high TTM cash from financing is $266.88M

What is Beta Bionics, Inc. TTM cash from financing year-on-year change?

Over the past year, BBNX TTM cash from financing has changed by +$165.95M (+164.42%)
On this page